Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

European approval for Velcade in multiple myeloma

April 30, 2004

New positive opinion for Herceptin plus Taxotere in E.U.

April 29, 2004

EntreMed completes phase I trial with reformulated Panzem

April 29, 2004

Allergan to withdraw PEP-005 INDs, resubmission planned

April 29, 2004

Cellular Genomics patent covers new protein kinase modulators

April 29, 2004

Two novel series of CDK inhibitors presented by Schering-Plough and Pharmacopeia

April 29, 2004

NF-kappaB inhibitor DHMEQ as treatment option for advanced urological cancer

April 29, 2004

Novel proteasome inhibitor ER807446 demonstrates antitumor activity especially against large tumors

April 29, 2004

ViRexx Medical receives grant to fund phase I trial of Occlusin

April 28, 2004

Phase III trial of Tarceva in NSCLC meets endpoints

April 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...